Superior graft-vs-leukemia effects after transplantation of murine allogeneic peripheral blood progenitor cells (PBPC) as compared to bone marrow.

被引：0
|
作者：
Zeis, M
Uharek, L
Glass, B
Steinmann, J
Dreger, P
Schmitz, N
机构：
[1] CHRISTIAN ALBRECHTS UNIV KIEL,DEPT INTERNAL MED 2,D-2300 KIEL,GERMANY
[2] CHRISTIAN ALBRECHTS UNIV KIEL,INST IMMUNOL,D-2300 KIEL,GERMANY
来源：
BLOOD | 1996年 / 88卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：970 / 970
页数：1
相关论文
共 50 条
  • [21] Relapse of chronic myelogenous leukemia 12 years after allogeneic marrow transplantation: Successful second transplantation with allogeneic peripheral blood progenitor cells
    Reiter, E
    Rabitsch, W
    Greinix, HT
    Keil, F
    Mitterbauer, G
    Hinterberger, W
    Haas, OA
    Lechner, K
    Kalhs, P
    LEUKEMIA & LYMPHOMA, 2000, 40 (1-2) : 215 - 218
  • [22] Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC)
    Bredeson, C
    Malcolm, J
    Davis, M
    BenceBruckler, I
    Kearns, B
    Huebsch, L
    BONE MARROW TRANSPLANTATION, 1997, 20 (10) : 889 - 896
  • [23] Transplantation of allogeneic peripheral blood progenitor cells (allo PBPC) - Impact on graft-versus-host disease (GVHD).
    Schmitz, N
    EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 602 - 602
  • [24] Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC)
    C Bredeson
    J Malcolm
    M Davis
    I Bence-Bruckler
    B Kearns
    L Huebsch
    Bone Marrow Transplantation, 1997, 20 : 889 - 896
  • [25] COMBINED TRANSPLANTATION OF ALLOGENEIC BONE-MARROW AND PERIPHERAL-BLOOD HEMATOPOIETIC PROGENITOR CELLS
    LINK, H
    ARSENIEV, L
    BAHRA, O
    BATTMAR, K
    KADAR, J
    JACOBS, R
    LOHMANN, D
    CASPER, J
    KUHL, J
    SCHUBERT, J
    DIEDRICH, H
    POLIWODA, H
    BLOOD, 1994, 84 (10) : A713 - A713
  • [26] Treatment of leukaemic relapse after allogeneic bone marrow transplantation (BMT) by transfusion of donor-type peripheral blood progenitor cells (PBPC)-analysis of hematopoietic chimerism
    Suttorp, M
    Dreger, P
    vonNeuhoff, N
    Haferlach, T
    Loffler, H
    Schmitz, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 480 - 480
  • [27] Allogeneic peripheral blood progenitor cell infusion for treatment of relapse after allogeneic bone marrow transplantation.
    Dreger, P
    Haferlach, T
    Winkemann, T
    Suttorp, M
    Loffler, H
    Schmitz, N
    BLOOD, 1995, 86 (10) : 1156 - 1156
  • [28] Natural killer cells given after allogeneic BMT induce strong graft-vs-leukemia (GVL) effects
    Zeis, M
    Uharek, L
    Glass, B
    Dreger, P
    Steinmann, J
    Schmitz, N
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 300 - 300
  • [29] Peripheral blood stem cells or bone marrow as the graft source for allogeneic hematopoietic cell transplantation?
    Alwasaidi, Turki
    Bredeson, Christopher
    JOURNAL OF TAIBAH UNIVERSITY MEDICAL SCIENCES, 2014, 9 (02): : 91 - 99
  • [30] Selection of CD34+ peripheral blood progenitor cells (PBPC) for allogeneic transplantation.
    UrbanoIspizua, A
    Rozman, C
    Marin, P
    Carreras, E
    Martinez, C
    Briones, J
    Merino, A
    Rovira, M
    Sierra, J
    Mazzara, R
    Montserrat, E
    BLOOD, 1995, 86 (10) : 901 - 901
12345